1,468
Views
13
CrossRef citations to date
0
Altmetric
Research Paper

Orthodenticle homeobox OTX1 is a potential prognostic biomarker for bladder cancer

, , &
Pages 6559-6571 | Received 17 Jun 2021, Accepted 25 Aug 2021, Published online: 24 Sep 2021

References

  • Antoni S, Ferlay J, Soerjomataram I, et al. Bladder cancer incidence and mortality: a global overview and recent trends. Eur Urol. 2017;71(1):96–108.
  • Lopez-Beltran A, Cimadamore A. Immune Checkpoint Inhibitors for The Treatment of Bladder Cancer. Cancers (Basel). 2021;13(1):131.
  • Szarvas T, Hoffmann MJ. MMP-7 Serum And Tissue Levels Are Associated with Poor Survival in Platinum-Treated Bladder Cancer Patients. Diagnostics (Basel). 2020;11(1):48.
  • Soria F, Krabbe LM, Todenhöfer T, et al. Molecular markers in bladder cancer. World J Urol. 2019;37(1):31–40.
  • DeGeorge KC, Holt HR, Hodges SC. Bladder cancer: diagnosis and treatment. Am Fam Physician. 2017;96(8):507–514.
  • Yang X, Ye T, Liu H, et al. expression Profiles, Biological Functions and Clinical Significance of Circrnas in Bladder Cancer Mol Cancer. 2021;20(1):4.
  • Mati Q, Qamar S, Ashraf S, et al. Tissue nuclear matrix protein expression 22 in various grades and stages of bladder cancer. J Coll Physicians Surg Pak. 2020;30(12):1321–1325.
  • Chen D, Cheng L, Cao H. Role of microRNA-381 in Bladder Cancer Growth and Metastasis with the Involvement of BMI1 and the Rho/ROCK Axis. BMC Urol. 2021;21(1):5.
  • Tang C, Wu Y, Wang X, et al. LncRNA MAFG-AS1 regulates miR-125b-5p/SphK1 axis to promote the proliferation, migration, and invasion of bladder cancer cells. Hum Cell. 2021 Mar; 34 (2):588-597.
  • Klein WH, Li X. Function and evolution of Otx proteins. Biochem Biophys Res Commun. 1999;258(2):229–233.
  • Omodei D, Acampora D, Russo F, et al. Expression of the brain transcription factor OTX1 occurs in a subset of normal germinal-center B cells and in aggressive Non-Hodgkin Lymphoma. Am J Pathol. 2009;175(6):2609–2617.
  • Larsen KB, Lutterodt M, Rath MF, et al. Expression of the homeobox genes PAX6, OTX2, and OTX1 in the early human fetal retina. Int J Dev Neurosci. 2009;27(5):485–492.
  • Pagani IS, Terrinoni A, Marenghi L, et al. The mammary gland and the homeobox gene Otx1. Breast J. 2010;16(Suppl 1):S53–6.
  • de Haas T, Oussoren E, Grajkowska W, et al. OTX1 and OTX2 expression correlates with the clinicopathologic classification of medulloblastomas. J Neuropathol Exp Neurol. 2006;65(2):176–186.
  • Terrinoni A, Pagani IS, Zucchi I, et al. OTX1 expression in breast cancer is regulated by p53. Oncogene. 2011;30(27):3096–3103.
  • Yu K, Cai XY, Li Q, et al. OTX1 promotes colorectal cancer progression through epithelial-mesenchymal transition. Biochem Biophys Res Commun. 2014;444(1):1–5.
  • Li H, Miao Q. OTX1 Contributes to Hepatocellular Carcinoma Progression by Regulation of ERK/MAPK Pathway. J Korean Med Sci. 2016 Aug;31(8):1215-23.
  • Li B, Cui Y, Diehn M, et al. Development and validation of an individualized immune prognostic signature in early-stage nonsquamous non-small cell lung cancer. JAMA Oncol. 2017;3(11):1529–1537.
  • Cui Z, Liu Y, Zhang J, et al. Super-delta2: an enhanced differential expression analysis procedure for multi-group comparisons of RNA-seq data. Bioinformatics (Oxford, England). 2021. DOI:10.1093/bioinformatics/btab155
  • Li GM, Zhang CL, Rui RP, et al. Bioinformatics analysis of common differential genes of coronary artery disease and ischemic cardiomyopathy. Eur Rev Med Pharmacol Sci. 2018;22(11):3553–3569.
  • Davis S, Meltzer PS. GEOquery: a bridge between the Gene Expression Omnibus (GEO) and bioconductor. Bioinformatics (Oxford, England). 2007;23(14):1846–1847.
  • Bolstad BM, Irizarry RA, Astrand M, et al. A comparison of normalization methods for high density oligonucleotide array data based on variance and bias. Bioinformatics (Oxford, England). 2003;19(2):185–193.
  • Smyth GK, Speed T. Normalization of cDNA microarray data. Methods. 2003;31(4):265–273.
  • Colaprico A, Silva TC, Olsen C, et al. TCGAbiolinks: An R/Bioconductor Package for Integrative Analysis of TCGA Data. Nucleic Acids Res. 2016 May 5;44(8):e71.
  • Silva TC, Colaprico A, Olsen C, et al. TCGA workflow: analyze cancer genomics and epigenomics data using bioconductor packages. F1000Res. 2016;5:1542.
  • Mounir M, Lucchetta M, Silva TC. New functionalities in the TCGAbiolinks package for the study and integration of cancer data from GDC and GTEx. PLoS Comput Biol. 2019;15(3):e1006701.
  • Sha Y, Phan JH, Wang MD. Effect of low-expression gene filtering on detection of differentially expressed genes in RNA-seq data. In Annual International Conference of the IEEE Engineering in Medicine and Biology Society IEEE Engineering in Medicine and Biology Society Annual International Conference,Milan, Italy, 2015;2015:6461–6464.
  • Cedric G. ggplot2: elegant graphics for data analysis. J R Stat Soc A Stat Soc. 2011;174:210.
  • Bittner ML, Chen Y, Dorsel AN, et al. Microarrays: optical technologies and informatics. Microarrays. 2001;4266.
  • Yang YH, Dudoit S, Luu P, et al. Normalization for cDNA microarray data: a robust composite method addressing single and multiple slide systematic variation. Nucleic Acids Res. 2002;30(4):e15.
  • Yang J, Thorne N. Normalization for two-color cDNA microarray data. Lecture Notes-Monograph Series 2003;40:403-418.
  • Christensen B, Kieler J, Vilien M, et al. A classification of human urothelial cells propagated in vitro. Anticancer Res. 1984;4(6):319–337.
  • Skopinska-Rózewska E, Janik P, Przybyszewska M, et al. Inhibitory effect of theobromine on induction of angiogenesis and VEGF mRNA expression in v-raf transfectants of human urothelial cells HCV-29. Int J Mol Med. 1998;2(6):649–652.
  • Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 2001;25(4):402–408.
  • Wu Q, Wang D, Zhang Z, et al. DEFB4A is a potential prognostic biomarker for colorectal cancer. Oncol Lett. 2020;20(4):114.
  • Tsui KH, Hsu SY, Chung LC, et al. Growth differentiation factor-15: a p53- and demethylation-upregulating gene represses cell proliferation, invasion, and tumorigenesis in bladder carcinoma cells. Sci Rep. 2015;5:12870.
  • Kampf C, Bergman J, Oksvold P, et al. A tool to facilitate clinical biomarker studies–a tissue dictionary based on the human protein atlas. BMC Med. 2012;10:103.
  • Pontén F, Gry M, Fagerberg L, et al. A global view of protein expression in human cells, tissues, and organs. Mol Syst Biol. 2009;5:337.
  • Farling KB. Bladder cancer: risk factors, diagnosis, and management. Nurse Pract. 2017;42(3):26–33.
  • Kirkali Z, Chan T, Manoharan M, et al. Bladder cancer: epidemiology, staging and grading, and diagnosis. Urology. 2005;66(6 Suppl 1):4–34.
  • Xu XF, Zhou X, Wang YJ, et al. Survival-associated transcriptome analysis in ovarian cancer. Eu J Gynaecol Oncol. 2020;41(3):455.
  • Ng K, Stenzl A, Sharma A, et al. Urinary biomarkers in bladder cancer: a review of the current landscape and future directions. Urol Oncol. 2021;39(1):41–51.
  • Wan S, Liu X, Hua W, et al. The role of telomerase reverse transcriptase (TERT) promoter mutations in prognosis in bladder cancer. Bioengineered. 2021;12(1):1495–1504.
  • Zhang F, Wang X, Hu H, et al. A hypoxia related long non-coding RNA signature could accurately predict survival outcomes in patients with bladder cancer. Bioengineered. 2021;12(1):3802–3823.
  • Shi S, Tian B. Identification of biomarkers associated with progression and prognosis in bladder cancer via co-expression analysis. Cancer Biomarkers. 2019;24(2):183–193.
  • Ye Y, An Y, Wang M, et al. Expression of carboxypeptidase X M14 family member 2 accelerates the progression of hepatocellular carcinoma via regulation of the gp130/JAK2/Stat1 pathway. Cancer Manag Res. 2020;12:2353–2364.
  • Meijuan W, Mao X, Wang S. Clinical significance of miR-139-5p and FGF2 in ovarian cancer. J BUON. 2021;26(3):663–669.
  • Ludlow AT, Wong MS, Robin JD, et al. NOVA1 Regulates hTERT Splicing and Cell Growth in Non-small Cell Lung Cancer. Nat Commun. 2018;9(1):3112.
  • Wang M, Dai M, Wu YS, et al. Immunoglobulin Superfamily Member 10 Is a Novel Prognostic Biomarker for Breast Cancer. PeerJ. 2020;8:e10128.
  • Ling B, Liao X, Huang Y, et al. Identification of prognostic markers of lung cancer through bioinformatics analysis and in vitro experiments. Int J Oncol. 2020;56(1):193–205.
  • Liu J, Zeng ML, Shi PC, et al. SCARA5 is a novel biomarker in colorectal cancer by comprehensive analysis. Clin Lab. 2020;66:7.
  • Acampora D, Barone P, Simeone A. Otx genes in corticogenesis and brain development. Cereb Cortex. 1999;9(6):533–542.
  • Wada S, Sudou N, Saiga H. Roles of Hroth, the ascidian otx gene, in the differentiation of the brain (sensory vesicle) and anterior trunk epidermis in the larval development of Halocynthia roretzi. Mech Dev. 2004;121(5):463–474.
  • Chen FY, Zhou ZY, Zhang KJ, et al. Long Non-coding RNA MIR100HG Promotes the Migration, Invasion and Proliferation of Triple-negative Breast Cancer Cells by Targeting the miR-5590-3p/OTX1 Axis. Cancer Cell Int. 2020;20:508.
  • Yang CY, Wang L, Mu DC, et al. OTX1 is a novel regulator of proliferation, migration, invasion and apoptosis in lung adenocarcinoma. Eur Rev Med Pharmacol Sci. 2020;24(18):9497–9510.
  • Tu XP, Li H, Chen LS, et al. OTX1 Exerts an Oncogenic Role and Is Negatively Regulated by miR129-5p in Laryngeal Squamous Cell Carcinoma. BMC Cancer. 2020;20(1):794.
  • Beukers W, van der Keur KA, Kandimalla R, et al. FGFR3, TERT and OTX1 as a urinary biomarker combination for surveillance of patients with bladder cancer in a large prospective multicenter study. J Urol. 2017;197(6):1410–1418.
  • Beukers W, Kandimalla R, van Houwelingen D, et al. The use of molecular analyses in voided urine for the assessment of patients with hematuria. PLoS One. 2013;8(10):e77657.
  • van Kessel KE, Beukers W, Lurkin I, et al. Validation of a DNA Methylation-Mutation Urine Assay to Select Patients with Hematuria for Cystoscopy. J Urology. 2017;197(3 Pt 1):590–595.
  • Qin SC, Zhao Z, Sheng JX, et al. Dowregulation of OTX1 attenuates gastric cancer cell proliferation, migration and invasion. Oncol Rep. 2018;40(4):1907–1916.